NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Island Pharmaceuticals Limited (AU: ILA)

 
ILA Technical Analysis
5
As on 19th Nov 2025 ILA STOCK Price closed @ 0.49 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.13 & Strong Buy for SHORT-TERM with Stoploss of 0.07 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ILASTOCK Price

Open 0.52 Change Price %
High 0.53 1 Day -0.04 -7.55
Low 0.48 1 Week 0.01 2.08
Close 0.49 1 Month 0.07 16.67
Volume 822186 1 Year 0.43 716.67
52 Week High 0.52 | 52 Week Low 0.06
 
AU Australia Most Active Stocks
HLX 0.00 %
CXO 0.22 0.00%
NTU 0.03 0.00%
DRO 1.97 -19.59%
ATC 0.02 -33.33%
LKE 0.06 20.00%
PLS 3.98 -2.69%
MEL 0.00 %
VR1 0.04 33.33%
AGY 0.07 16.67%
 
AU Australia Top Gainers Stocks
APV 0.02 100.00%
FRX 0.02 100.00%
FRX 0.02 100.00%
FRX 0.02 100.00%
8CO 0.03 50.00%
8CO 0.03 50.00%
8CO 0.03 50.00%
SCI 0.03 50.00%
SCI 0.03 50.00%
SCI 0.03 50.00%
 
AU Australia Top Losers Stocks
BNL 0.00 -100.00%
BNL 0.00 -100.00%
WLD 0.01 -66.67%
M2M 0.01 -50.00%
ATC 0.02 -33.33%
ATC 0.02 -33.33%
ATC 0.02 -33.33%
ATC 0.02 -33.33%
RCP 0.02 -33.33%
RCP 0.02 -33.33%
 
 
ILA
Daily Charts
ILA
Intraday Charts
Whats New @
Bazaartrend
ILA
Free Analysis
 
ILA Important Levels Intraday
RESISTANCE0.59
RESISTANCE0.56
RESISTANCE0.54
RESISTANCE0.52
SUPPORT0.46
SUPPORT0.44
SUPPORT0.42
SUPPORT0.39
 
ILA Forecast November 2025
4th UP Forecast0.51
3rd UP Forecast0.5
2nd UP Forecast0.5
1st UP Forecast0.5
1st DOWN Forecast0.48
2nd DOWN Forecast0.48
3rd DOWN Forecast0.48
4th DOWN Forecast0.47
 
ILA Weekly Forecast
4th UP Forecast0.49
3rd UP Forecast0.49
2nd UP Forecast0.49
1st UP Forecast0.49
1st DOWN Forecast0.49
2nd DOWN Forecast0.49
3rd DOWN Forecast0.49
4th DOWN Forecast0.49
 
ILA Forecast2025
4th UP Forecast1.53
3rd UP Forecast1.2
2nd UP Forecast0.99
1st UP Forecast0.78
1st DOWN Forecast0.2
2nd DOWN Forecast-0.01
3rd DOWN Forecast-0.22
4th DOWN Forecast-0.55
 
 
ILA Other Details
Segment EQ
Market Capital 25909918.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ILA Address
ILA
 
ILA Latest News
 
Your Comments and Response on Island Pharmaceuticals Limited
 
ILA Business Profile
Island Pharmaceuticals Limited, a drug research and repurposing company, focuses on the development of preventative or therapeutic drugs for viral infections. Its lead product candidate is ISLA-101, a drug for the prevention and treatment of dengue fever and other mosquito borne diseases. Island Pharmaceuticals Limited has a research collaboration agreement with Monash University to screen known molecules against host targets; research and development collaboration with Griffith University to screen for active anti-viral molecules in a rational repurposing strategy; research collaboration agreement with Compounds Australia, a drug library containing approximately four and a half thousand molecules that could be searched for drug re-purposing and pipeline development; cooperative research and development agreement with the U.S. Army in preparation for its Phase II clinical study for ISLA-101; supply agreement with Catalent for manufacture of Fenretinide softgels for dengue fever trial participants; and right to reference National Cancer Institute IND for Isla101. The company was founded in 2017 and is based in Camberwell, Australia. Address: 697 Burke Road, Camberwell, VIC, Australia, 3124
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service